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Abstract
Rationale An acute challengewith delta-9-tetrahydrocannabinol
(THC) can induce psychotic symptoms including delusions.
High electroencephalography (EEG) frequencies, above 20 Hz,
have previously been implicated in psychosis and schizophrenia.
Objectives The objective of this study is to determine the
effect of intravenous THC compared to placebo on high-
frequency EEG.
Methods A double-blind cross-over study design was used. In
the resting state, the high-beta to low-gamma magnitude (21–
45 Hz) was investigated (n=13 pairs+4 THC only). Also, the
event-related synchronisation (ERS) of motor-associated high
gamma was studied using a self-paced button press task (n=15).
Results In the resting state, there was a significant condition ×
frequency interaction (p=0.00017), consisting of a shift to-
wards higher frequencies under THC conditions (reduced
high beta [21–27 Hz] and increased low gamma [27–
45 Hz]). There was also a condition × frequency × location
interaction (p=0.006), such that the reduction in 21–27-Hz
magnitude tended to be more prominent in anterior regions,
whilst posterior areas tended to show greater 27–45-Hz in-
creases. This effect was correlated with positive symptoms, as
assessed on the Positive and Negative Syndrome Scale
(PANSS) (r=0.429, p=0.042). In the motor task, there was a
main effect of THC to increase 65–130-Hz ERS (p=0.035)
over contra-lateral sensorimotor areas, which was driven by
increased magnitude in the higher, 85–130-Hz band (p=0.02)
and not the 65–85-Hz band.
Conclusions The THC-induced shift to faster gamma oscilla-
tions may represent an over-activation of the cortex, possibly
related to saliency misattribution in the delusional state.
Keywords THC . EEG . Beta . Gamma . Psychosis .
Cannabis
Introduction
There is evidence that the chronic use of Δ9-tetrahydrocan-
nabinol (THC) is a risk factor for schizophrenia (Andreasson
et al. 1987; Arseneault et al. 2002; Henquet et al. 2005; Moore
et al. 2007). Moreover, acute administration of Δ9-THC has
been shown to produce transient psychotic symptoms in
healthy subjects, particularly delusions, (D’Souza et al.
2004; Morrison et al. 2009), thus modelling some of the
symptoms of schizophrenia (Luzi et al. 2008; D’Souza et al.
2009; Koethe et al. 2009).
Neural oscillations, which are repetitive increases and de-
creases in neuronal or synaptic activity, are known to be impor-
tant in brain function and to generate waves in the electrical
fields which can be detected at the scalp using electroencepha-
lography (EEG). EEG oscillations can be measured in three
main ways: Firstly, phase-locking of oscillations to an event,
such as a stimulus presentation or response, can be measured
using event-related potentials, inter-trial coherence, evokedmag-
nitude or steady-state responses to a rapid stimulus train.
Secondly, resting-state magnitude of the waves can be recorded
without reference to any events. Thirdly, changes in magnitude,
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due to an event, can be quantified ignoring phase locking. In this
case, an increase in magnitude is termed an event-related syn-
chronisation (ERS) and a decrease in magnitude is an event-
related desynchronisation (ERD). Cannabinoids have been re-
ported to alter the EEG signal. Firstly, THC tends to reduce
phase-related measures; there is a dose-dependent reduction of
the P300 with acute THC (D’Souza et al. 2012) and reduced
inter-trial coherence. (Stone et al. 2012). Furthermore, in chronic
cannabis users, Auditory Steady-State Responses (ASSRs) to
40-Hz click trains have been found to be reduced (Skosnik et al.
2012), demonstrating an impairment in the capacity of neural
circuits to support gamma band oscillations. These changes are
similar to reductions in event-related potentials and phase
locking observed in schizophrenia (Kwon et al. 1999; Bramon
et al. 2005; Spencer et al. 2008; Hall et al. 2011), although there
have been contradictory results (Spencer and Ghorashi 2014).
THC also causes changes in neural oscillations independent of
phase locking to an event. In humans, acute THC has been
shown to reduce the magnitude and coherence of lower frequen-
cies of the human EEG spectra (Ilan et al. 2005; Zuurman et al.
2008; Bocker et al. 2010; Morrison et al. 2011; Stone et al.
2012). Moreover, animal studies have demonstrated that
cannabinoid-1 (CB1) agonists, such as Δ9-THC, significantly
affect neuronal oscillations in the gamma band (>30 Hz) (Robbe
et al. 2006; Hajos et al. 2008). In psychotic disorders, including
schizophrenia, both increases and decreases in EEG magnitude
at rest have been reported in psychotic disorders including
schizophrenia (Giannitrapani and Kayton 1974; Itil 1977;
Venables et al. 2009; Ranlund et al. 2014). Changes have also
been observed in task-related gamma band activity, such as
decreased ERS in an auditory task occurring at frontal and left-
sided locations but increased ERS in posterior and right loca-
tions (Haig et al. 2000). Synchrony between different brain areas
is also altered above 20 Hz, being reduced at 20–30 Hz in
schizophrenia in a Gestalt task (Uhlhaas et al. 2006) but in-
creased at rest in temporal areas in the 35–45-Hz low-gamma
(LG) band (Flynn et al. 2008).More recently task-related deficits
at high-gamma (HG) frequencies (>60 Hz) have been observed
using MEG (Uhlhaas 2011; Uhlhaas et al. 2011). Since aberrant
salience attribution is thought to underlie delusions (Kapur
2003) and a higher peak frequency of gamma may reflect the
saliency of a stimulus (van Pelt and Fries 2013), the frequency
distribution of high-frequency oscillations may be important in
psychosis, but this has not yet been investigated.
Cannabinoids could alter cortical oscillations either via acti-
vation of cortical receptors or indirectly via sub-cortical struc-
tures, such as the basal ganglia. THC acts mainly on CB1
receptors, which are particularly dense in the components of
cortico-striatal circuits (Herkenham et al. 1990). The main areas
involved in the limbic, or reward, cortico-striatal circuit are the
nucleus accumbens, prefrontal cortical areas and temporal areas
including the hippocampus (Alexander et al. 1986; Haber and
Knutson 2010), whereas the putamen and motor cortical areas
are key nodes in the motor striatal circuit, with the cerebellum
being a key target area (Alexander et al. 1986). There is evidence
that functional dysconnectivity in cortico-striatal circuitry is an
important risk phenotype for psychosis (Dandash et al. 2014;
Fornito et al. 2013), whilst antipsychotics are thought to act by
antagonism of the dopamine D2 receptors in these circuits.
Stimulation of dopamine receptors using L-DOPA can alleviate
the motor symptoms of Parkinson’s but also generate psychotic
symptoms as a side effect, whilst antipsychotics can give rise to
parkinsonian symptoms as side effects. Understanding the ef-
fects of THC on these circuits may be key to understanding the
mechanism by which THC generates psychosis. Out of the sub-
components of these circuits, only some areas of neocortex are
close enough to the surface of the brain for the low-amplitude
high-frequency waves to be clearly detected on the scalp using
EEG. For example, in a self-paced motor task, ERS occurs at
high-gamma power which can be detected in the EEG,mainly at
65–85 Hz, but extending up to 130 Hz (Crone et al. 1998;
Cheyne et al. 2008; Nottage et al. 2013). Limbic and associative
cortico-striatal circuits, which are of relevance to psychosis, will
be active during internal thought processes in the resting state,
but the exact timing of such activity is unknown, precluding the
use of themore sensitive event-related EEGmeasures. However,
since dopamine induces similar effects in all striatal circuits,
THCmight also act in a similar way. Thus, changes in the motor
gamma signal, which can be readily measured, could shed light
on the general effects of THC on high-frequency oscillations in
cortico-striatal circuits. Whereas the motor high-gamma activity
is localised to the contra-lateral motor and somatosensory cortex,
resting-state activity is more widely distributed, whilst high-
frequency topographic effects of THC are unknown. It is of
interest that frontal cortical regions have higher CB1 expression
than posterior regions (Glass et al. 1997), the neural circuits
through the striatum and thalamus to the cortex project mainly to
frontal areas (Herrero et al. 2002), and altered CB1 signalling in
prefrontal areas may be important in schizophrenia (Dalton et al.
2011). Also, since changes in gammaERS in opposite directions
in anterior-posterior and posterior regions are reported in schizo-
phrenia (Haig et al. 2000), we asked whether the effect of THC
on high-frequency oscillations in the frontal cortex would be
different to its effect on posterior cortical areas.
There has been considerable recent concern about the con-
tamination of frequencies above 20 Hz by muscle activity from
the scalp, neck and eyes (Goncharova et al. 2003;Whitham et al.
2007; Yuval-Greenberg et al. 2008). In response to this concern,
novel artefact reduction techniques have been developed, both to
deal with extra-ocular muscle activity (Keren et al. 2010;
Nottage 2010; Hassler et al. 2011) and contamination from scalp
and neckmuscles (Nottage et al. 2013). It has been demonstrated
that these can increase the signal to noise ratio of the motor
gamma ERS. Therefore, whilst the effect of THC on the resting
human EEG spectra up and including 20 Hz has been well
established, the effect of acute THC on higher frequencies needs
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to be clarified using improved artefact correction. A standard
frequency band for high beta is 20–30 Hz, whereas the frequen-
cies used for low gamma have varied, usually starting at 30–
35 Hz with an upper bound between 40 and 60 Hz. However,
increased EEG magnitude confined to a narrow frequency band
around 30 Hz has been reported at rest in acute schizophrenia
(Giannitrapani and Kayton 1974) and more recently as a re-
bound ERS after a visual task (Spencer and Ghorashi 2014).
Hence, a 30-Hz division between high beta and low gamma is
inappropriate here, since it would obscure any such peak. Also,
the amplitude of EMG continues to increase with frequency up
to at least 60 Hz (Goncharova et al. 2003), whereas the peak of
low gamma is thought to be around 40 Hz, so using an upper
bound of 45 Hz for the low-gamma analysis would yield a
greater signal to noise ratio than using 60 Hz.
We also hypothesised that THC-induced effects would
correlate with psychopathology as measured using the
Positive and Negative Syndrome Scale (PANSS) (Kay et al.
1987). Since there is evidence that THC acts by exacerbating
an underlying predisposition to psychosis (McGuire et al.
1995; Arendt et al. 2008; Barkus and Lewis 2008), it is the
final magnitude of the EEG, as opposed to the change induced
by THC, that is likely to be most strongly associated with
positive symptoms. However, the raw magnitude of resting
EEG can vary considerably between subjects, due in part to
physical features such as skull thickness. Where changes in
frequency or topography are present, the use of ratios of the
EEG magnitudes at different frequencies or electrode loca-
tions can help reduce this inter-subject variance.
In summary, this study investigates the effect of intrave-
nous THC on resting-state 21–45-Hz magnitude and on the
contra-lateral high-gamma 65–130-Hz response to self-paced
motor responses. Changes in the frequency distribution of the
EEG were considered, as well as changes in the fronto-
posterior distribution in the resting state and associations with
PANSS positive symptoms.
Materials and methods
Subjects
Ethical approval was given by the South London and Maudsley
Ethics Committee, and the research was therefore performed in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki. All participants gave written informed
consent. A randomised, double-blind, within-participant, exper-
imental design was employed. Intravenous (IV) THC (1.25 mg)
or placebo was administered, and resting-state EEG was record-
ed approximately 10 min post-injection, followed by a self-
paced motor task at 20 min post-injection. For 15 subjects,
EEG was recorded during a self-paced motor task for THC
and placebo sessions. Resting-state EEG was recorded for both
THC and placebo sessions for 14 participants and for just the
THC session for a further four participants. In one subject,
excessive muscle artefact contamination meant that data quality
was insufficient to allow processing of high-frequency EEG
data, leaving 13 subjects with both THC and placebo resting-
state data. Mean age of all participants was 26±6 years, and
59 % were female. Before the experimental sessions, all urine
drug screens were negative. Previous use of cannabis ranged
from 2 to ~1,000 occasions (median=40). All participants had
used cannabis with previous use of cannabis ranging from 2 to
~4,000 occasions (median=100). With regard to other drugs,
76 % had previously taken stimulants (cocaine/amphetamines),
41 % had taken psychedelics (psilocybin/LSD), and there was a
single case of gamma-hydroxybutyric acid use. All participants
had consumed alcohol, and 53 % were smoking tobacco at the
time of testing.
EEG recording
EEG was recorded using a Neuroscan 64 channel Synamps
amplifier using the 10–20 system with a linked mastoid ref-
erence. Additional electrodes were positioned at the outer
corners of the left and right eyes and the power-line noise
was also recorded. The sampling rate was 2,000 Hz, resolution
was 0.1 μV, and filter settings were 0.05 (high pass) to 200 Hz
(low pass).
Tasks
Resting-state EEG was recorded for at least 2 min, whilst
participants were sitting in a chair with arm supports. Every
30 s, a verbal instruction was given to the participant to open
or close their eyes. Only the eyes-closed data was included in
the analysis, to avoid contamination with artefacts from the
eyes. For the self-paced motor task, the participants were
instructed to press a button with their index finger, on a game
pad located next to their right hand, approximately once per
second. After 70 button presses the words “task finished”
appeared on the computer screen.
EEG analysis
Frequencies above 20 Hz were analysed using methods de-
scribed in detail elsewhere (Nottage 2010; Nottage et al.
2013). In brief, power-line noise was reduced by noise can-
cellation, and the micro-saccade artefacts were removed using
regression in the motor task. The scalp, face and neck EMG
was reduced by mathematical modelling and subtraction of
individual muscle spikes, for all epochs in which the 60–140-
Hz amplitude exceeded 0.03 μV/Hz at any time point. The
thresholds for the minimum amplitude of EMG spike were set
at 7 μV for <85 Hz and 4 μV for >85 Hz. After artefact
correction, sliding windows of 256 ms, 5 ms apart, were cut
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for high motor gamma (>65 Hz), giving frequency bins
3.91 Hz wide, and 512 ms, 50 ms apart, for high beta/low
gamma (21–45 Hz), giving frequency bins 1.95 Hz wide. A
frequency-based rejection procedure was used as described
previously (Nottage et al. 2013). After linear detrending and
applying Hanning windows, FFTs were applied. The initial
preprocessing stages were carried out in Neuroscan 4.3, after
which the analysis was carried out inMATLAB, including use
of the Signal Processing Toolbox.
Electrode derivations and frequency bands: resting state
The 21–45-Hz frequency band was divided into three sub-
bands, each with a band width of one quarter of its central
frequency, giving high beta (21–27 Hz), beta/gamma (27–
35 Hz) and low gamma (35–45 Hz). This allowed the analysis
to be sensitive to a narrow spectral peak at 30 Hz, as well as
other changes in frequency distribution. In order to apply the
EMG reduction, there should only be one source of muscle
spikes. Therefore, midline electrodes (FZ, FCZ, CZ, PZ and
CPZ), which are relatively free from EMG contamination
(Fitzgibbon et al. 2013), were used as reference electrodes,
to generate 32 bipolar channels, as shown in Fig. 1. These
were divided into two groups, anterior and posterior, as shown
by the hatched and solid fill areas in Fig. 1, and amplitude
values for each group were averaged before further analysis.
Electrode derivations and frequency bands: motor task
A left central bipolar channel (C3-CZ) was used for the
65–130-Hz band, which was sub-divided into high gamma
(65–85 Hz) and very high gamma (85–130 Hz) so that
changes in frequency distribution could be detected. The
event-related synchronisation (ERS) in the 250 ms follow-
ing the button press was calculated using the period −550
to −75 ms as the baseline. A button press was excluded if it
followed the previous one by less than 875 ms.
Statistical tests
Statistical analysis was carried out using SPSS statistical
analysis software. For the motor gamma ERS, a paired two-
tailed t test was carried out on the whole 65–130 Hz band. In
the case of a significant effect, the frequency distribution of
this effect was explored using further t tests with the two sub-
bands (65–85 Hz and 85–130 Hz), using Bonferroni correc-
tion for multiple comparisons. In the resting-state data, a
repeated measures ANOVAwas carried out with three factors:
condition (drug and placebo), location (anterior and posterior)
and frequency (20–27, 27–35 and 35–45 Hz). If sphericity
assumptions were violated, Huynh-Feldt corrections were
applied. Where significant main EEG amplitude effects were
observed, Kendall’s tau correlation coefficients were calculat-
ed between PANSS positive scores and the amplitudes and
tested for significance using two-tailed tests. If interaction
effects were uncovered in the ANOVA, ratios of the relevant
EEG amplitudes were calculated, in order to minimise
subject to subject variance, and used to test for symp-
tom associations. Bonferroni correction for multiple
comparisons was used where necessary. To determine
whether there was a specific association between the
electrophysiological effects and delusions, a sub-group
of the PANSS scores, consisting of those primarily
associated with delusions (P1+P5+P6: delusions, gran-
diosity and persecution/suspiciousness), was also tested.
In the resting EEG, the effect of THC on frequencies below
20 Hz was also analysed and is presented in Supplement 1.
Results
Resting state
We did not observe a main effect of condition in the 21–45 Hz
band, (F=0.226, p=0.634, η2partial=0.018), but we did find a
significant main effect of frequency (p<0.0001) and a condition
× frequency interaction (F=15.90, p=0.00017, η2partial=0.570).
This effect consisted of an upwards shift in frequency from the
21–27-Hz band to the 27–35 and 35–45-Hz bands under THC,
Fig. 1 Bipolar montage used for resting-state analysis. The hatched area
denotes electrodes in the anterior group, and the solid fill those in the
posterior group. Each line corresponds to a bipolar electrode derivation,
such as F7-FCZ or O2-PZ
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which can be seen in the mean spectra in Fig. 2. There was also a
condition ×frequency × location interaction (F=6.32, p=0.006,
η2partial=0.345). The THC-induced reduction in 21–27-Hz am-
plitude was relatively greater in frontal areas, whereas the in-
crease in 27–45-Hz magnitude tended to be relatively greater in
posterior regions. To explore the relationship between these
frequency and spatial effects and symptom scores, two ratios
were calculated. Firstly, the overall mean 27–45-Hz amplitude
was divided by the 21–27-Hz amplitude, but this first ratio was
not correlated with PANSS positive symptom scores. Secondly,
to take into account the location effect as well as the frequency
effect, the posterior 27–45-Hz amplitude was divided by the
anterior 21–27-Hz amplitude (Table 1). This ratio did show a
positive association with PANSS positive symptom scores
(r=0.429, p=0.021) (see Fig. 3a) in the THC condition,
which was still significant after correction for multiple
comparisons (p=0.042). Within this correlation with pos-
itive symptom scores, the strongest association was with
delusion-associated scores (PANSS items P1+P5+P6)
(r=0.525, p=0.016, after correction for multiple compar-
isons) (see Fig. 3b).
Self-paced motor task: high-gamma ERS
The 65–130-Hz ERS was significantly greater with THC than
placebo (p=0.035). To explore the frequency distribution of
this effect, using t tests with the two-frequency bands sepa-
rately, a significant increase was observed in the 85–130-Hz
band only (placebo −0.002 μV (SD 0.030), THC 0.031 μV
(SD 0.033), p=0.02, after correcting for multiple comparisons)
but not in the lower-frequency band 65–85 Hz μV (placebo
0.014 (SD 0.020), THC 0.026 μV (SD 0.046), p=0.339, before
correction for multiple comparisons) (see Fig. 4).
The distribution of ERS values against PANSS positive
scores is shown in Fig. 3c. The correlation between PANSS
positive scores and the magnitude of the gamma ERS of the
broad (65–130 Hz) frequency band was not significant.
However, the increase in gamma was driven by the seven
subjects who had detectable delusional symptoms, since re-
peating the t tests with only these subjects still showed a
significant increase in ERS with THC in both the 65–130-
Hz band (p=0.023) and in the higher, 85–130-Hz sub-band
(p=0.036 after correction for multiple comparisons).
Discussion
The effect of intravenous THC on the EEG
This study set out to investigate the effects of intravenous
THC on high-frequency EEG activity during the resting-state
and self-paced motor responses. The novel aspect of the
analysis presented here is the application of artefact reduction
methods to allow the higher frequencies of the scalp EEG to
be investigated with greater confidence. Intravenous THCwas
found to shift the resting-state spectra towards an increase in
the higher-frequency component in the high-beta to low-
gamma band and to increase the higher-frequency sub-band
of the motor-associated high gamma. In the resting state, an
association with PANSS positive symptom scores, particularly
Fig. 2 Mean spectra over all subjects: a anterior and b posterior. The THC-induced shift in magnitude from below 27 Hz to above 27 Hz is visible in
both pairs of spectra
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scores for delusions, grandiosity and persecution/suspiciousness,
was observed.
Resting-state EEG magnitude effects induced by THC
The previously reported reduction in resting theta with THC
(Bocker et al. 2010) was present in our data (Supplement 1).
However, our observed magnitude reductions in frequencies
between 20 and 27 Hz with THC are difficult to compare
directly with previous reports, which do not focus on the same
frequency bands, and Böcker and colleagues observed com-
plex, dose-dependent changes in the power of resting ‘beta’
with 29 to 69 mg of smoked THC at mastoid referenced
midline electrodes. (Bocker et al. 2010). However, this was
in a frequency range of 12–30 Hz, and the spectra shown in
their Fig. 6 indicate that power is increased above around
24 Hz but that this is partly outweighed by a decrease in
power between 12 and 20 Hz, consistent with our high-
frequency resting results. Zuurman and colleagues also report-
ed a reduction in 11.5–30-Hz beta using inhalational THC
(Zuurman et al. 2008) in a posterior bipolar channel.
Comparison with animal studies
Our finding of increased gamma magnitude in the THC
sessions appears to differ from reports of the effect of
CB1 agonists in rodents, where in the hippocampus, pre-
frontal and entorhinal cortex, the gamma magnitude is
generally decreased (Robbe et al. 2006; Hajos et al.
2008; Kucewicz et al. 2011). However, the contribution
of hippocampal electrical activity to human scalp EEG
recordings is minimal, and therefore, the effects on neo-
cortical gamma will be more relevant. Also, it should be
noted that our experiments were carried out less than an
hour after the THC injection and that by 2 h, most of the
psychotic symptoms had faded. However, in temporal
areas in freely moving rats, decreased gamma magnitude
was not apparent until 2 h after the injection (Hajos et al.
2008; Kucewicz et al. 2011). To the contrary, in the
entorhinal cortex during the first hour post-injection, the
power of both low (30–50 Hz) and high gamma (62–
90 Hz) increased (Hajos et al. 2008), which is consistent
with our results in humans. However, timing cannot ex-
plain the differences in prefrontal areas, since, in a recent
animal study, a CB1 agonist induced a reduction in pre-
frontal gamma magnitude in rats during the first hour after
injection (Kucewicz et al. 2011). Whilst the prefrontal
regions and spatial scale of the local field potentials
sampled by the rat electrodes will not be identical to
human prefrontal scalp EEG and different CB1 agonists
were used, our results might be due to a genuine species
difference in the effect of CB1 agonists on prefrontal
gamma (Kucewicz et al. 2011). However, it should also
be noted that the increase in gamma in our data was less
pronounced in frontal than other regions.
High-frequency neural oscillations and acute psychosis
It has been previously reported that frequencies above
22 Hz in posterior electrode locations are increased during
THC-induced hallucinations compared to the non-
hallucinating state, although the effect of scalp and neck
muscle activity on these results is unclear (Koukkou and
Lehmann 1976). Both ketamine, which can induce psy-
chosis at sub-anaesthetic doses in humans, and MK-801
give rise to a hypersynchronous and persistent 30–80-Hz
gamma noise in the parietal, occipital and frontal cortices
in awake rats (Hakami et al. 2009), and ketamine also
affects oscillations in the rodent basal-ganglian motor
system (Nicolas et al. 2011). In an animal model of
schizophrenia, but not in controls, ketamine has been
shown to produce a peak in gamma above 130 Hz in
motor systems (Phillips et al. 2012), which may be related
to our finding of an increase in the higher frequency
component of motor gamma. Furthermore, amphetamine
induces a shift from resting 50 to 80–100 Hz in rat ventral
striatum (Berke 2009). This suggests the possibility that
the shift to higher frequencies might be a general correlate
of agents which induce psychosis. It is of interest that, in
addition to much research activity around schizophrenia
and gamma, increases in cortical gamma have also been
implicated in the induction of false sensory perceptions in
humans, such as in tinnitus, somatic hallucinations
(Baldeweg et al. 1998) and visual illusions (Adjamian
et al. 2004; Weisz et al. 2007). In fact in intracranial
stimulation of the tinnitus, hotspot suggests that there
may be a causal relationship between tinnitus and EEG
changes in the gamma frequency (De Ridder et al. 2011).
Table 1 Resting-state amplitudes
Mean (SD) μV/Hz (Hz) Anterior Posterior
Placebo THC Placebo THC
21–27 0.548 (0.190) 0.495 (0.208) 0.506 (0.133) 0.484 (0.149)
27–35 0.419 (0.159) 0.408 (0.178) 0.337 (0.066) 0.345 (0.114)
35–45 0.306 (0.079) 0.323 (0.089) 0.244 (0.057) 0.259 (0.862)
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High frequencies in motor systems
CB1 receptors are dense in many components of motor sys-
tems, including the cerebellum (Herkenham et al. 1990). The
relationship between high-frequency oscillations and pathol-
ogy in motor systems has been much explored with regard to
Parkinson’s disease. Akinesia, in Parkinson’s, has been argued
to be due to an abnormally persistent beta 15–30-Hz oscilla-
tion in motor systems, whilst oscillations at frequencies above
70 Hz are thought to be pro-kinetic (Brown and Williams
2005; Schnitzler and Gross 2005) This high-frequency gam-
ma is disinhibited by the dopamine agonists used to treat the
disease, which can also induce psychosis. Our observation
that THC also increases high-frequency motor gamma mag-
nitude suggests that these two drug effects might be related.
Also, it is of interest that deep brain stimulation of the sub-
thalamic nucleus, typically at 130 Hz, is increasingly used to
treat Parkinson’s patients. There is evidence that the
Fig. 3 PANSS scores and observed effects. a, b Association with the
ratio of posterior 27–45-Hz magnitude to frontal 20–27-Hz magnitude in
the resting state. a Total positive scores. b Total delusion-related scores:
P1, P5 and P6. c Motor gamma ERS and positive symptoms. Gray dots
are placebo sessions and black triangles are THC sessions. The trend line
was fitted for THC sessions only
Fig. 4 Motor event-related synchronisation at a left central location (C3-
CZ). The white box highlights the THC-induced increase in 85–130-Hz
ERS in the 250 ms after the button press, whilst the black box outlines the
65–85-Hz ERS. The amplitudes have been baseline corrected to the
500 ms before the button press. Scale is in μV/Hz
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mechanism of this effect is antidromic conduction of these
130-Hz oscillations back to layer V pyramid cells in the motor
cortex (Dejean et al. 2009; Gradinaru et al. 2009). Our ob-
served shift from beta to gamma in the resting state might be
interpreted as an activation of cognitive systems by THC
which is analogous to the high-frequency activation of motor
systems by dopamine agonists.
Possible mechanisms for the frequency shift
There are two possible levels of explanation for the upwards
frequency shift: either it is a direct effect within the neocortex or
it is a secondary effect mediated via sub-cortical structures and
feeding back on to the cortex. On the neocortical level, CB1
receptors inhibit GABA release from CCK-immunoreactive,
irregular spiking inter-neurons (Bodor et al. 2005; Galarreta
et al. 2008), which could be expected to produce an increase
in excitation of the pyramid cell and parvalbumin-
immunoreactive fast spiking inter-neuron ‘PING’ network re-
sponsible for generating neocortical gamma (Whittington et al.
2011), as previously pointed out by others (Robbe et al. 2006).
Increasing the excitatory inputs to such a network can increase
the frequency of the oscillations (see Fig. 1b inWhittington et al.
(2011)). If the peak frequency of gamma is an index of saliency
(van Pelt and Fries 2013), then this would imply that THC
induces both aberrant salience and delusions (Kapur 2003) by
a direct action on the cortex. However, this would be inconsis-
tent with research implicating sub-cortical D2 signalling in
delusion formation in schizophrenia (Howes and Kapur 2009).
How might the THC-induced increase in higher frequency
neural oscillations be mediated via a sub-cortical pathway? As
discussed above, in the motor basal ganglia, THC produces
similar effects to dopamine on neural oscillations. It could
therefore be speculated that the process involves dopamine-
like effects in non-motor regions of the basal ganglia, such as
the nucleus accumbens (NA) or caudate nucleus. Information
processing in these basal ganglia areas might be impaired by
THC-induced theta desynchronisation of hippocampal and the
prefrontal afferents on to these regions (Goto and Grace 2008;
Morrison et al. 2011). This could produce a feed forward deficit
in the information transmitted to areas which induce or syn-
chronise cortical gamma and beta oscillations, such as cholin-
ergic centres (Metherate et al. 1992; Verrico et al. 2003; Roopun
et al. 2010), particularly the pedunculopontine nucleus, or
intralaminar or posterior thalamic nuclei. Functional basal
ganglia-tecto-thalamic circuits are known to exist, including
connections with gamma-inducing areas (Leh et al. 2008;
Redgrave et al. 2010). Motor gamma has been postulated to
be dependent on the centromedian and parafascicular nuclei of
the thalamus (Jenkinson et al. 2013) whereas the pulvinar may
mediate the resting-state effects (Bouyer et al. 1981;
Shumikhina and Molotchnikoff 1999). The pulvinar, which in
cats synchronises visual gamma and beta oscillations
(Shumikhina and Molotchnikoff 1999), cannot be identified
in rodents and has connections with the prefrontal and temporal
areas in primates (Romanski et al. 1997), including humans
(Leh et al. 2008). Involvement of the pulvinar would explain
the difference in the effect of CB1 agonists on prefrontal
gamma power in rodents (Kucewicz et al. 2011) and humans.
Also, the pulvinar is thought to mediate salience (Robinson and
Petersen 1992), and delusions can be induced by a lesion in the
pulvinar (Crail-Melendez et al. 2013).
Whatever the cause of the upward shift in frequency, it is of
interest that we found resting-state beta, which has a function to
maintain the status quo (Engel and Fries 2010), being replaced
by gamma, which is associated with the active processing of
signals (Fries et al. 2001; Sohal et al. 2009). This gamma over-
activity may lead to neuronal noise being given excessive pro-
cessing, leading to false inferences. In higher-order brain regions,
this may produce erroneous interpretations of the social environ-
ment which are manifested in a THC-induced paranoid delusion.
In summary, at frequencies above 20 Hz, intravenous THC
increases the magnitude of higher-frequency components,
especially in motor and posterior cortex. These changes cor-
relate with positive symptom scores on the PANSS scale. The
shift from lower to higher frequencies under THC may reflect
a cortical over-activation which could underlie the induction
of positive symptoms by THC.
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